These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36423067)
1. A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association? Ambrogio F; Laface C; Sbarra G; Filotico R; Ranieri G; Barlusconi C; De Marco A; Cazzato G; Bonamonte D; Romita P; Foti C Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423067 [TBL] [Abstract][Full Text] [Related]
2. Phototherapy as an effective treatment for Majocchi's disease--case report. Dhali TK; Chahar M; Haroon MA An Bras Dermatol; 2015; 90(1):96-9. PubMed ID: 25672304 [TBL] [Abstract][Full Text] [Related]
3. Purpura annularis telangiectodes of Majocchi: A case report. Pu YJ; Jiang HJ; Zhang L World J Clin Cases; 2023 Jun; 11(16):3858-3863. PubMed ID: 37383137 [TBL] [Abstract][Full Text] [Related]
4. Purpura annularis telangiectodes of Majocchi. Hale EK Dermatol Online J; 2003 Oct; 9(4):17. PubMed ID: 14594590 [TBL] [Abstract][Full Text] [Related]
5. Unilateral purpura annularis telangiectodes of majocchi in an elderly male: an atypical presentation. Wang A; Shuja F; Chan A; Wasko C Dermatol Online J; 2013 Aug; 19(8):19263. PubMed ID: 24021442 [TBL] [Abstract][Full Text] [Related]
6. Purpura annularis telangiectodes of Majocchi: case report and review of the literature. Hoesly FJ; Huerter CJ; Shehan JM Int J Dermatol; 2009 Oct; 48(10):1129-33. PubMed ID: 19775410 [TBL] [Abstract][Full Text] [Related]
7. [Purpura annularis telangiectodes : Case report and review of the literature]. Burghaus J; Enk A; Toberer F Hautarzt; 2021 Jan; 72(1):65-70. PubMed ID: 32803361 [TBL] [Abstract][Full Text] [Related]
8. Flu vaccine-induced purpura annularis telangiectodes of Majocchi. Baklouti M; Sellami K; Chaabouni R; Masmoudi A; Daldoul M; Hammami S; Charfi S; Zghal K; Sellami T; Turki H Therapie; 2022; 77(4):496-498. PubMed ID: 34175124 [No Abstract] [Full Text] [Related]
9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
11. A case of certolizumab-induced purpura annularis telangiectodes of Majocchi and literature review. Karstarlı Bakay OS; Bakay U Int J Rheum Dis; 2024 Jan; 27(1):e14854. PubMed ID: 37522716 [TBL] [Abstract][Full Text] [Related]
12. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
13. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700 [TBL] [Abstract][Full Text] [Related]
14. Purpura annularis telangiectoides. Miller K; Fischer M; Kamino H; Meehan S; Cohen D Dermatol Online J; 2012 Dec; 18(12):5. PubMed ID: 23286795 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine. Farid E; Herrera-Uribe J; Stevenson NJ Front Immunol; 2022; 13():817597. PubMed ID: 35711448 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
17. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines. Melgoza-González EA; Hinojosa-Trujillo D; Reséndiz-Sandoval M; Mata-Haro V; Hernández-Valenzuela S; García-Vega M; Bravo-Parra M; Arvizu-Flores AA; Valenzuela O; Velázquez E; Soto-Gaxiola A; Gómez-Meza MB; Pérez-Jacobo F; Villela L; Hernández J Transbound Emerg Dis; 2022 Jul; 69(4):e734-e745. PubMed ID: 34655457 [TBL] [Abstract][Full Text] [Related]
18. Pigmented purpuric eruptions. Newton RC; Raimer SS Dermatol Clin; 1985 Jan; 3(1):165-9. PubMed ID: 4092379 [TBL] [Abstract][Full Text] [Related]
19. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore. Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588 [TBL] [Abstract][Full Text] [Related]
20. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.]. Casas Fischer R Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]